Intelligent Bio Solutions (INBS) Equity Average (2020 - 2025)

Intelligent Bio Solutions has reported Equity Average for 6 years, with the latest figure at $4.0 million in Q2 2025.

• For the quarter ending Q2 2025, Equity Average fell 58.61% year-over-year to $4.0 million; the trailing twelve-month figure through Jun 2025 stood at $4.0 million (down 58.61% YoY), and the FY2025 full-year result was $5.6 million, down 5.82% from the prior year.
• Equity Average for Q2 2025 stood at $4.0 million, down from $4.6 million in the prior quarter.
• The five-year high for Equity Average was $17.3 million in Q1 2021, with the low at $2.2 million in Q4 2023.
• Average Equity Average over 5 years is $8.0 million, with a median of $7.4 million recorded in 2022.
• Year-over-year, Equity Average surged 445.03% in 2021 and slumped 71.6% in 2023.
• Tracing INBS's Equity Average over 5 years: stood at $11.8 million in 2021, then tumbled by 34.35% to $7.7 million in 2022, then tumbled by 71.6% to $2.2 million in 2023, then jumped by 131.23% to $5.1 million in 2024, then declined by 21.79% to $4.0 million in 2025.
• The last three Equity Average figures came in at $4.0 million (Q2 2025), $4.6 million (Q1 2025), and $5.1 million (Q4 2024), per Business Quant data.

Peer Comparison